Home › NDC Lookup › Ingredients › Glycerin, Lidocaine, And Witch Hazel › 10157-2112-01
Tucks Multi-Care Relief Kit (Tucks Hemorrhoidal and Tucks Medicated Cooling 40 Count) GLYCERIN, LIDOCAINE, and WITCH HAZEL Kit — NDC 10157-2112-01 package photo
Label image from the product's FDA listing (DailyMed) — may show a different pack size or an older label revision.

Tucks Multi-Care Relief Kit (Tucks Hemorrhoidal and Tucks Medicated Cooling 40 Count) GLYCERIN, LIDOCAINE, and WITCH HAZEL Kit — NDC 10157-2112-1 (Billing 10157-2112-01)

by Blistex Inc · 1 KIT in 1 CARTON * 14 g in 1 TUBE * 1 mL in 1 APPLICATOR

This is a package of Tucks Multi-Care Relief Kit (Tucks Hemorrhoidal and Tucks Medicated Cooling 40 Count) GLYCERIN, LIDOCAINE, and WITCH HAZEL Kit from Blistex Inc, marketed since Feb 2019 and currently FDA-listed. It is this product's only package size.

NDC 10157-2112-01
🏷️ FDA NDC (as labeled) 10157-2112-1 billing pads the package segment with a zero
OTC On market Non-controlled ⇄ Compare with another NDC
🗂️ FDA directory synced Oct 1, 2026 · this listing last changed Jul 24, 2026 · sources: openFDA · FDA label (DailyMed) · FDA Orange & Purple Book · First Databank · CMS NADAC, ASP, Medicare & Medicaid · RxNorm
📋 All sources & update times →

This page is curated, coded, and maintained by

Compiled from public FDA, CMS, DailyMed, NADAC, and related drug data sources. Editorial policy

Identity & classification

Regulatory identifiers FDA, NLM and CMS codes for this package

FDA NDC (as labeled) 10157-2112-1
Product NDC 10157-2112
11-digit billing NDC 10157211201
RxCUI 2117860
Application # M015
SPL Set ID a7cb6d78-3048-43b3-afe7-4d862fdcfd3f
DEA schedule Non-controlled
Marketing category OTC MONOGRAPH DRUG
Marketing status On market
FDA listing status Listed (active directory)
Marketing start 2019-02-15
Dosage form KIT
Quick answers
  • RxCUI (RxNorm): 2117860
Why two NDCs? The FDA registers this code as 10157-2112-1 — a 5-4-1 layout, and that's what's printed on the package and shown on DailyMed. For insurance claims, every NDC is standardized to a uniform 11-digit 5-4-2 format by adding a zero to the package segment → 10157-2112-01. Same drug, same package — only the format differs.
Where does this data come from?
Identifiers from the FDA openFDA NDC Directory and Structured Product Labeling; RxCUI from RxNorm (NLM); GPI from Medi-Span; GCN / HIC / AHFS / legend from First Databank.

RxNorm drug class

This medicine belongs to the Non-Standardized Chemical Allergen class.

Pharmacologic class Non-Standardized Chemical Allergen
Drug family (ATC) Enemas, Other drugs for constipation
Where does this data come from?
Therapeutic classes from RxNorm RxClass (U.S. National Library of Medicine) — Established Pharmacologic Class (FDA), ATC drug family (WHO) and mechanism of action, matched by this product’s RxCUI.

Clinical

🧪 What is this product?

Tucks Multi-Care Relief Kit is an over-the-counter product sold as a kit containing medicated pads and cooling gel. It contains glycerin, lidocaine, and witch hazel as active ingredients. Lidocaine is a local anesthetic typically used to numb minor pain and discomfort. Witch hazel and glycerin are astringent and soothing agents commonly used in products meant to reduce irritation and provide temporary relief in the rectal area.

Supplement & herbal interactions

🌿 Drug–supplement interaction checker →
Where does this data come from?
Plain-language summary from MedlinePlus (U.S. National Library of Medicine); supplement & herbal interactions and nutrient depletion data from the Natural Medicines database; our full guide is HelloPharmacist editorial content.

Pricing

A drug doesn't have one price. Each row is a different public payment system, and none is what you'd pay at the counter — that depends on your insurance. The ⓘ on each row explains what it measures.

Price systemPer eachPer package
Retail pharmacies payNADAC · weekly Not in the retail survey — common for institutional, discontinued, or low-volume packs.
Medicaid paysCMS SDUD · 12 mo No recent Medicaid claims on file for this NDC — rare and low-volume NDCs are suppressed in the public data.
Medicare drug plans payPart D · quarterly No Part D plan price is available for this NDC in our data.
ℹ️
No price is published for this exact package yet. CMS surveys NADAC per package size, so a different pack of the same drug often has one.
Where does this data come from?
NADAC (National Average Drug Acquisition Cost) is the CMS weekly pharmacy-acquisition-cost survey — what pharmacies pay. ASP (Average Sales Price) is the CMS Medicare Part B drug-payment file, published quarterly. Medicaid pays is computed by us from CMS State Drug Utilization Data (total reimbursed ÷ units, trailing 12 months) — gross of rebates and inclusive of dispensing fees, so it reflects what Medicaid paid, not an acquisition cost. Medicare drug plans pay is the median negotiated point-of-sale unit cost across plans listing this NDC in the CMS quarterly Prescription Drug Plan pricing files, before rebates. The VA pays is the federal contract price (FSS, and the statutory Big 4 ceiling where listed) from the VA National Acquisition Center pharmaceutical price file. All are free public government data; each measures a different payer, so the figures are not directly comparable.

Packaging — all sizes for this product

Package NDCDescription Marketing startMarketing endStatus
10157-2112-01 You're viewing this Main listing 1 KIT in 1 CARTON * 14 g in 1 TUBE * 1 mL in 1 APPLICATOR 2019-02-15 — Active

Therapeutic equivalents

ProductLabelerPackNADAC/unitTEStatusPrice vs. this
Tucks Multi-Care Relief Kit (Tucks Hemorrhoidal and Tucks Medicated Cooling 40 Count)this 10157-2112-01 Blistex 1 kit — — FDA listed —
About this product: other versions of the same ingredient, strength and form are listed above, least expensive first, with FDA equivalence ratings where available.
Where does this data come from?
Equivalents are other NDCs of the same ingredient, form and route from the openFDA NDC Directory, ranked least-expensive-first by NADAC. Therapeutic-equivalence (AB) ratings come from the FDA Orange Book; biologics use the FDA Purple Book for biosimilar & interchangeable status.

Availability & generic status

🏛️
2019
On the market since
Feb 2019
📍
2026
Currently FDA-listed
7 years listed
🔒
·
No generic listed yet
brand only
ℹ️No FDA-approved generic found

We did not find an FDA-approved generic match for this exact strength, form and route.

Where does this data come from?
Patents and exclusivity from the FDA Orange Book (small-molecule drugs), refreshed from public FDA data. Generic launch timing is an estimate, not a guarantee.

Inactive Ingredients / Excipients

Inactive ingredients, also called excipients, are components of the drug product other than the active ingredient. They may include fillers, dyes, coatings, preservatives, flavors, or other formulation ingredients.

From the label’s inactive-ingredient sectionarachidyl alcohol, arachidyl glucoside, avena sativa kernel flour (colloidal oatmeal), behenyl alcohol, disodium EDTA, ethylhexylglycerin, microcrystalline wax, petrolatum, phenoxyethanol, polyglyceryl-3 diisostearate, polysorbate 60, purified water, sorbitan isostearate, stearyl behenate citric acid, disodium EDTA, ethylhexylglycerin, glycerin, phenoxyethanol, potassium sorbate, purified water, sodium citrate

This is label-wide narrative text, not a normalized exact-product ingredient list. A label can cover multiple strengths or packages.

Where does this data come from?
Source: official FDA Structured Product Labeling (SPL) via DailyMed and the openFDA label index. Structured IACT rows and label-wide narrative are kept separate; availability and product-level specificity depend on the submitted label.

Inactive ingredient FAQ

Are inactive ingredients the same for every manufacturer?
No. Inactive ingredients can differ by manufacturer, dosage form, strength, and package / product version.
Why might an inactive ingredient be missing?
Some SPLs do not provide a complete structured inactive-ingredient list, and older or unusual labels may only include the information in narrative text.
Can inactive ingredients matter?
Yes. They can matter for allergies, intolerances, dyes, gluten / lactose concerns, preservatives, and formulation differences — but confirm with a pharmacist or the manufacturer when it’s clinically important.

Manufacturer & labeler

LabelerBlistex Inc
FDA applicationM015 (OTC MONOGRAPH DRUG)
Labeler code10157
First marketedFeb 2019
Product typeHuman Otc Drug
Portfolio15 products on file
The labeler markets the product; the application holder owns the FDA approval. They’re often the same company but can differ (e.g. a repackager or an authorized generic). A mailing address / phone appears here when the manufacturer includes it in the product’s FDA label (not all do).
Where does this data come from?
Labeler, application holder and registered establishment from the FDA openFDA NDC Directory and Drugs@FDA; address/contact from the product’s FDA label.

FDA label — Drug Facts FDA SPL

The complete FDA label for this product — the official Drug Facts labeling, verbatim, section by section. Jump with a chip, search within the label, or expand everything.
🎯 Indications and Usage ⏱️ Dosage and Administration ⚠️ Warnings 📦 Storage and Handling 🧪 Active Ingredient 🧪 Inactive Ingredients 🎯 Purpose 📄 When Using This Product 📄 Stop Use and Ask a Doctor If 📄 Keep Out of Reach of Children 📄 Package Label / Principal Display Panel
🎯 Indications and Usage 49 words ▾

Uses temporarily relieves the local pain, itching and discomfort associated with hemorrhoids temporarily provides a coating for relief of anorectal discomforts temporarily relieves rectal irritation and burning

Uses temporarily relieves the local itching and discomfort associated with hemorrhoids aids in protecting irritated anorectal areas temporarily relieves irritation and burning

⏱️ Dosage and Administration 115 words ▾

Directions Adults: when practical, clean the affected area with mild soap and warm water and rinse thoroughly  gently dry by patting or blotting with toilet tissue or a soft cloth before applying apply externally to the affected area up to 6 times daily or after each bowel movement Children under 12 years of age: ask a doctor

Directions Adults: when practical, clean the affected area with mild soap and warm water and rinse thoroughly gently dry by patting or blotting with toilet tissue or a soft cloth before applying apply externally to the affected area up to 6 times daily or after each bowel movement Children under 12 years of age: ask a doctor

⚠️ Warnings 192 words ▾

Warnings For external use only When using this product do not exceed the recommended daily dosage unless directed to do so by a doctor do not put directly in the rectum by using fingers or any mechanical device or applicator Stop use and ask a doctor if rectal bleeding occurs condition worsens or does not improve within 7 days certain persons can develop allergic reactions to ingredients in this product. If the symptom being treated does not subside or if redness, irritation, swelling, pain, or other symptoms develop or increase, discontinue use and consult a doctor.

Keep out of reach of children. If swallowed, get medical help or contact a Poison Control Center right away.

Warnings For external use only When using this product do not use more than directed unless told to do so by a doctor do not put directly in the rectum by using fingers or any mechanical device or applicator Stop use and ask a doctor if rectal bleeding occurs condition worsens or does not improve within 7 days Keep out of reach of children. If swallowed, get medical help or contact a Poison Control Center right away.

📦 Storage and Handling 61 words ▾

Other information DO NOT FLUSH - after application, discard pad in trash and wash hands for use as a moist compress — if necessary, first cleanse the area and place wipe in contact with irritated area for a soothing and cooling effect. Leave in place for up to 15 minutes and repeat as needed but not to exceed directions for use

🧪 Active Ingredient 18 words ▾

Active ingredients Purpose Glycerin 15.0% (w/w) Protectant Lidocaine 5.0% (w/w) Local anesthetic

Active ingredient Witch hazel (50% w/w)

🧪 Inactive Ingredients 46 words ▾

Inactive ingredients arachidyl alcohol, arachidyl glucoside, avena sativa kernel flour (colloidal oatmeal), behenyl alcohol, disodium EDTA, ethylhexylglycerin, microcrystalline wax, petrolatum, phenoxyethanol, polyglyceryl-3 diisostearate, polysorbate 60, purified water, sorbitan isostearate, stearyl behenate

Inactive ingredients citric acid, disodium EDTA, ethylhexylglycerin, glycerin, phenoxyethanol, potassium sorbate, purified water, sodium citrate

🎯 Purpose 14 words ▾

Active ingredients Purpose Glycerin 15.0% (w/w) Protectant Lidocaine 5.0% (w/w) Local anesthetic

Purpose Astringent

📄 When Using This Product 69 words ▾

When using this product do not exceed the recommended daily dosage unless directed to do so by a doctor do not put directly in the rectum by using fingers or any mechanical device or applicator

When using this product do not use more than directed unless told to do so by a doctor do not put directly in the rectum by using fingers or any mechanical device or applicator

📄 Stop Use and Ask a Doctor If 75 words ▾

Stop use and ask a doctor if rectal bleeding occurs condition worsens or does not improve within 7 days certain persons can develop allergic reactions to ingredients in this product. If the symptom being treated does not subside or if redness, irritation, swelling, pain, or other symptoms develop or increase, discontinue use and consult a doctor.

Stop use and ask a doctor if rectal bleeding occurs condition worsens or does not improve within 7 days

📄 Keep Out of Reach of Children 38 words ▾

Keep out of reach of children. If swallowed, get medical help or contact a Poison Control Center right away.

Keep out of reach of children. If swallowed, get medical help or contact a Poison Control Center right away.

📄 Package Label / Principal Display Panel 83 words ▾

PRINCIPAL DISPLAY PANEL - Kit Carton TUCKS ® MULTI-CARE RELIEF KIT Cream: Local Anesthetic / Protectant Pads: Astringent Lidocaine 5% Cream to numb & protect painful hemorrhoids + Witch Hazel Pads to cleanse & soothe rectal or vaginal areas TUCKS ® HEMORRHOIDAL CREAM MAXIMUM STRENGTH LIDOCAINE with Colloidal Oatmeal TUCKS ® MEDICATED COOLING PADS WITH WITCH HAZEL 40 PADS with Ultra-soft Fabric Net Wt. 0.5 oz. (14 g) - 1 Tube 2-Product Value 40 Pads 1 Jar Principal Display Panel - Kit Carton

Source: FDA Structured Product Labeling, mirrored from DailyMed / openFDA. Prefer the government’s original formatting? View this label on DailyMed ↗

About this NDC listing & data coverage

Over-the-counter (OTC) product Kit / multi-component package

Kit / multi-component package

This NDC identifies a kit — a package containing more than one component. Structured data (pricing, ingredients, equivalents) is often reported per component rather than for the kit NDC itself, which can make this page look thinner than the components' own pages.

What data is (and isn’t) available for this NDC — tap to expand
NDC identity (package / product / labeler codes) ✓ Available
Labeler ✓ Available
Product & package description ✓ Available
Marketing category & status ✓ Available
Active ingredient / dosage form / route ✓ Available
FDA label (SPL via DailyMed) ✓ Available
Package photos ✓ Available
Inactive ingredients (structured) ✓ Available
NADAC pharmacy acquisition price (CMS) — Not published for this NDC CMS publishes NADAC only for NDCs reported in its retail-pharmacy survey.
Orange Book / therapeutic-equivalence data — Not published for this NDC Applies only to products approved under an NDA/ANDA; many listings are out of scope.
HCPCS J-code billing crosswalk — Not published for this NDC Most self-administered / retail products have no J-code — that is normal.
Medicaid utilization (CMS SDUD) — Not published for this NDC CMS reports utilization only for NDCs with Medicaid claims above its privacy threshold.
“Not published” reflects what the public FDA / CMS / NLM sources provide for this exact package code — it is a property of the data feeds, not a judgment about the product.

Questions about this listing

Is this NDC FDA-approved?
An NDC listing does not by itself establish FDA approval — the NDC Directory records that a product is listed with FDA, not that it was reviewed and approved. This listing's marketing category is "Otc Monograph Drug". Products approved under an application carry an NDA, ANDA, or BLA number.
Why is there no price listed?
The pricing shown on our NDC pages comes from CMS NADAC, a voluntary survey of retail community pharmacy invoices. CMS does not publish a NADAC for every NDC — packages outside the retail survey (institutional and hospital products, bulk packages, discontinued items, and many OTC items) may never receive one. A missing price reflects the survey's scope, not this product's actual cost, and does not mean the product is free or unavailable.
Is the NDC printed on the package the same as the 11-digit billing NDC?
Yes, they identify this exact package in different formats. The form printed on the packaging and shown on DailyMed is the one the FDA registered. Insurance claims use a fixed 11-digit 5-4-2 format, so the short segment is padded with a leading zero and the dashes are dropped. The Identity section at the top of this page lists each form of this code.
Is this package still being marketed?
Yes, per the latest FDA NDC Directory data on this page: this package is listed as actively marketed, with no marketing end date reported by Blistex Inc. Listing status can change — the directory data on this page refreshes weekly.
Who lists this product with the FDA?
Blistex Inc is the labeler of record for this NDC — the company under whose FDA-assigned code the package is listed. The labeler may be the manufacturer itself or a distributor marketing the product under its own code.
Do I need a prescription for this product?
This NDC is listed with FDA as an over-the-counter product, so it does not require a prescription. Follow the package directions, and ask your pharmacist if you are unsure whether it is right for you.
This page identifies an FDA-listed package (the NDC) and reports public regulatory and pricing data about the listing. It is reference information, not a medical recommendation — talk to your pharmacist or prescriber about your own medication.
Where does this data come from?
Listing facts (marketing category, packager status, marketing dates) from the FDA openFDA NDC Directory; label availability from DailyMed; pricing coverage from CMS NADAC; equivalence scope from the FDA Orange Book.
← 10157-2106-01 · Blistex 10157-2114-01 · Blistex →
For educational and professional reference only — not medical advice. Pricing reflects published NADAC and CMS ASP (free public data) and may differ from your acquisition cost; always verify before billing or dispensing.